Delayed transient neurologic toxicity due to tacrolimus: CT and MRI

Neuroradiology

Volumn 42, Issue 9, 2000, Pages 666-668

  Bova, D ^a   Shownkeen, H ^a   Goldberg, K ^a   Horowitz, S ^a   Azar Kia, B ^a  

^a LOYOLA UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

Bone marrow transplant; Computed tomography; Immunosuppressive therapy, complications; Magnetic resonance imaging; White matter

Indexed keywords

ANTIBIOTIC AGENT; ANTIVIRUS AGENT; CORTICOSTEROID; CYCLOSPORIN A; IMMUNOSUPPRESSIVE AGENT; TACROLIMUS;

ADULT; ARTICLE; BONE MARROW TRANSPLANTATION; CASE REPORT; CASE STUDY; CLINICAL FEATURE; COMPUTER ASSISTED TOMOGRAPHY; DRUG ACTIVITY; GRAFT REJECTION; HUMAN; IMAGING SYSTEM; IMMUNOSUPPRESSIVE TREATMENT; MALE; NEUROTOXICITY; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; REMISSION;

EID: 0033820050     PISSN: 00283940     EISSN: None     Source Type: Journal    
DOI: 10.1007/s002340000298     Document Type: Article

References (9)

1. Neuroimaging findings in patients on immunosuppressive therapy: Experience with tacrolimus toxicity
2. Tacrolimus (FK-506)-induced cerebral blindness following bone marrow transplantation
3. Cortical blindness and white matter lesions in a patient receiving FK 506 after liver transplantation
4. Cerebral vasculitis during FK-506 treatment in a liver transplant patient
5. Cyclosporine-related reversible posterior leukoencephalopathy: MRI
6. Cyclosporine A toxicity: MRI appearance of the brain
7. Reversible intracerebral pathologic entities mediated by vascular autoregulatory dysfunction
8. Severe neurotoxicity after liver transplantation: Association between FK 506 therapy and hepatitis C virus disease
9. Watershed imaging features and clinical vascular injury in cyclosporine a toxicity